Vaxxinity, Inc. announced the appointment of Jason Pesile as Senior Vice President, Finance & Accounting. The company also announced the appointment of George Hornig, Chairman of Xometry, to its Board of Directors. Mr. Hornig will be the new independent director to chair the Audit Committee, with current Board members Greg Blatt and Peter Diamandis moving to chair the Compensation Committee and Nominating and Governance Committee, respectively.

Mr. Pesile is a seasoned finance executive with 20 years of experience in the biopharmaceutical space and most recently served as Vice President Finance, Corporate Controller at BeyondSpring Pharmaceuticals. He has worked at multiple biopharma companies in the past 10 years, where he led various aspects of financial operations, including accounting, financial reporting, audit and financial planning. Earlier in his career, Jason worked in management consulting and as a global project manager at Schering-Plough and Merck focused on post-merger integration.

Mr. Hornig is currently Chairman of Xometry, an AI-driven platform for on-demand manufacturing of industrial parts, and Co-Chairman (and Audit Chairman) of Healthwell Acquisition Corp., a special purpose acquisition company. Mr. Hornig is also Managing Partner and Co-Founder of The Seed Lab, an early-stage venture fund. From 2010-2016, Mr. Hornig was Senior Managing Director and COO of PineBridge Investments (formerly AIG Investment Management).

Prior to joining PineBridge, Mr. Hornig spent 11 years at Credit Suisse Asset Management as Managing Director and Global COO.